From: Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women
MTCT | No. | Neonatal morality | Early mortality | ||||
---|---|---|---|---|---|---|---|
 |  | Mortality Rate (n) | Crude HR (95% CI) | Adjusted HR(95% CI)e | Mortality Rate (n) | Crude HR (95% CI) | Adjusted HR(95% CI)f |
Model 1 a | Â | Â | Â | Â | Â | Â | Â |
IU | 64 | 0.050 (3) | 1.09 (0.34–3.50) | 0.97 (0.30–3.18) | 0.137 (8) | 2.26 (1.08–4.73) | 1.65 (0.77–3.50) |
IP/ePP | 64 | 0.016 (1) | 0.35 (0.05–2.51) | 0.39 (0.05–2.85) | 0.048 (3) | 0.78 (0.25–2.50) | 1.11 (0.35–3.58) |
NI at least for 42 days | 1004 | 0.044 (43) | 1.0 | Â | 0.059 (56) | 1.0 | Â |
Model 2 b | Â | Â | Â | Â | Â | Â | Â |
IU | 114 | 0.268 (26) | 14.82 (8.25–26.60) | 12.03 (6.45–22.42) | 0.347 (32) | 12.65 (7.73–20.72) | 8.15 (4.83–13.74) |
IP/ePP | 64 | 0.016 (1) | 0.73 (0.10–5.40) | 0.73 (0.10–5.47) | 0.048 (3) | 1.34 (0.41–4.39) | 1.70 (0.52–5.58) |
NI at least for 42 days | 954 | 0.022 (20) | 1.0 | Â | 0.035 (32) | 1.0 | Â |
Model 3 c | Â | Â | Â | Â | Â | Â | Â |
IU | 64 | 0.050 (3) | 2.28 (0.68–7.68) | 1.88 (0.55–6.43) | 0.137 (8) | 3.89 (1.79–8.44) | 2.70 (1.23–5.91) |
IP/ePP | 114 | 0.238 (24) | 13.15 (7.25–23.84) | 11.65 (6.23–21.79) | 0.275 (27) | 9.92 (5.93–16.58) | 9.61 (5.58–16.54) |
NI at least for 42 days | 954 | 0.022 (20) | 1.0 | Â | 0.035 (32) | 1.0 | Â |
Model 4 d | Â | Â | Â | Â | Â | Â | Â |
IU | 67 | 0.080 (5) | 1.94 (0.77–4.93) | 1.66 (0.65–4.29) | 0.164 (10) | 2.98 (1.52–5.87) | 2.09 (1.05–4.17) |
IP/ePP | 67 | 0.045 (3) | 1.13 (0.35–3.65) | 0.82 (0.20–3.41) | 0.076 (5) | 1.39 (0.56–3.48) | 1.55 (0.56–4.32) |
NI at least for 42 days | 998 | 0.040 (39) | 1.0 | Â | 0.055 (52) | 1.0 | Â |